Home » Archive by Tags

Articles tagged with: GENZ

Genzyme Receives FDA Letter (NASDAQ:GENZ)
10/07/2009 – 9:00 am PDT | No Comment

Genzyme Corporation has announced that they have received a complete response letter from the Food and Drug Administration about the company’s supplemental New Drug Application for Clolar in patients suffering from acute myeloid leukemia or …

Clolar Gets Cool Reception From FDA and up for Approval (GENZ, VION)
09/01/2009 – 3:22 pm PDT | No Comment

Genzyme Corporation (Nasdaq:GENZ) has a new drug application for their new drug Clofarabine ( Clolar), a leukemia drug that will be used to treat older patients.
The Food and Drug Administration criticized the biotech company’s clinical …